MX2012002621A - Un metodo de cristalizacion de clorhidrato de (s)-n-metil-3-(1-naftiloxi)-3-(2-tienil)propilamina (duloxetina). - Google Patents

Un metodo de cristalizacion de clorhidrato de (s)-n-metil-3-(1-naftiloxi)-3-(2-tienil)propilamina (duloxetina).

Info

Publication number
MX2012002621A
MX2012002621A MX2012002621A MX2012002621A MX2012002621A MX 2012002621 A MX2012002621 A MX 2012002621A MX 2012002621 A MX2012002621 A MX 2012002621A MX 2012002621 A MX2012002621 A MX 2012002621A MX 2012002621 A MX2012002621 A MX 2012002621A
Authority
MX
Mexico
Prior art keywords
duloxetine
thienyl
methyl
phthyloxy
crystallization
Prior art date
Application number
MX2012002621A
Other languages
English (en)
Spanish (es)
Inventor
Ludek Ridvan
Josef Cinibulk
Veronika Grunwaldova
Hana Brusova
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of MX2012002621A publication Critical patent/MX2012002621A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
MX2012002621A 2009-09-02 2010-09-02 Un metodo de cristalizacion de clorhidrato de (s)-n-metil-3-(1-naftiloxi)-3-(2-tienil)propilamina (duloxetina). MX2012002621A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2009-584A CZ304602B6 (cs) 2009-09-02 2009-09-02 Způsob krystalizace hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (hydrochloridu duloxetinu)
PCT/CZ2010/000099 WO2011026449A1 (en) 2009-09-02 2010-09-02 A method of crystallization of (s)-n-methyl-3-(1-naphthyloxy)-3- (2-thienyl)propylamine hydrochloride (duloxetine)

Publications (1)

Publication Number Publication Date
MX2012002621A true MX2012002621A (es) 2012-07-03

Family

ID=43413356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002621A MX2012002621A (es) 2009-09-02 2010-09-02 Un metodo de cristalizacion de clorhidrato de (s)-n-metil-3-(1-naftiloxi)-3-(2-tienil)propilamina (duloxetina).

Country Status (11)

Country Link
EP (1) EP2473497A1 (pt)
JP (1) JP2013503823A (pt)
KR (1) KR20120047262A (pt)
CN (1) CN102482254A (pt)
BR (1) BR112012004862A2 (pt)
CZ (1) CZ304602B6 (pt)
EA (1) EA021528B1 (pt)
IL (1) IL218329A0 (pt)
MX (1) MX2012002621A (pt)
WO (1) WO2011026449A1 (pt)
ZA (1) ZA201201570B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103626735A (zh) * 2012-08-28 2014-03-12 石药集团中奇制药技术（石家庄）有限公司 一种盐酸度洛西汀晶型及其制备方法
CN104478849A (zh) * 2014-02-14 2015-04-01 广东东阳光药业有限公司 制备去甲肾上腺素再摄取双重抑制剂的方法
CN106265528A (zh) * 2015-05-12 2017-01-04 法德生技药品股份有限公司 制备药物凝集体的方法
JP2016222628A (ja) * 2015-06-03 2016-12-28 株式会社トクヤマ デュロキセチン塩酸塩の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007433A (ko) 1986-12-22 1988-08-27 메리 앤 터커 3-아릴옥시-3-치환된 프로판아민
US5362886A (en) 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
DE10212301A1 (de) 2002-03-20 2003-10-02 Bayer Ag Verfahren zur Herstellung von Aryl-aminopropanolen
WO2004005239A1 (en) 2002-07-09 2004-01-15 Lonza Ag PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED β-AMINO ALCOHOLS
GB0410470D0 (en) * 2004-05-11 2004-06-16 Cipla Ltd Pharmaceutical compound and polymorphs thereof
CZ297560B6 (cs) * 2004-10-26 2007-02-07 Zentiva, A. S. Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu)
EP1874754A1 (en) * 2005-03-14 2008-01-09 Teva Pharmaceutical Industries Ltd Pure duloxetine hydrochloride
EP1820800A1 (en) * 2006-02-17 2007-08-22 KRKA, tovarna zdravil, d.d., Novo mesto Crystalline forms of duloxetine hydrochloride and processes for their preparation
GB0612508D0 (en) * 2006-06-23 2006-08-02 Arrow Int Ltd Crystalline duloxetine hydrochloride
GB0612509D0 (en) * 2006-06-23 2006-08-02 Arrow Int Ltd Crystalline duloxetine hydrochloride
CZ300116B6 (cs) * 2006-12-05 2009-02-11 Zentiva, A. S. Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu
EP2132192B1 (en) * 2007-03-05 2013-04-24 Lupin Limited Novel process for preparation of duloxetine hydrochloride

Also Published As

Publication number Publication date
KR20120047262A (ko) 2012-05-11
EA201290127A1 (ru) 2013-02-28
CN102482254A (zh) 2012-05-30
CZ304602B6 (cs) 2014-07-30
ZA201201570B (en) 2013-08-28
IL218329A0 (en) 2012-04-30
EA021528B1 (ru) 2015-07-30
EP2473497A1 (en) 2012-07-11
WO2011026449A1 (en) 2011-03-10
CZ2009584A3 (cs) 2011-03-09
JP2013503823A (ja) 2013-02-04
BR112012004862A2 (pt) 2015-09-08

Similar Documents

Publication Publication Date Title
MY161598A (en) Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
MX2012002621A (es) Un metodo de cristalizacion de clorhidrato de (s)-n-metil-3-(1-naftiloxi)-3-(2-tienil)propilamina (duloxetina).
IL180798A0 (en) Process for modifying offset voltage characteristics of an interferometric modulator
GB2511224A (en) Golf club heads with turbulators and methods to manufacture golf club heads with turbulators
ZA200909030B (en) Method for the production of n-substituted (3-dihalomethyl-1-methyl-pyrazole-4-yl)carboxamides
FR3007582B1 (fr) Procede d'impression ou de depot par atomisation pour la preparation d'une electrode flexible supportee et la fabrication d'une batterie lithium-ion
MX2012014085A (es) Metodo de entrenamiento tactico utilizando una extructura portatil y una estructura portatil.
BRPI1014396A2 (pt) bobina de eletrodo, célula galvânica , bateria,método para produzir uma bobina de eletrodo, método para operar uma bateria e método para operar uma célula galvânica
EA200801833A1 (ru) Способы получения кристаллических форм дулоксетина гидрохлорида
MX2013011194A (es) Ahorro de energia adapatable para una unidad de suscriptor movil en una red de comunicacion inalambrica.
GB0712788D0 (en) Clock frequency adjustment within an SoC
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EP1938581A4 (en) INTERNAL STORAGE OF CAMERA CHARACTERISTICS DURING PRODUCTION
EA201000398A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EP2431362A4 (en) 3- (4-AMINOPHENYL) -2-FURANCARIC ACID DERIVATIVE AND PHARMACEUTICAL ACCEPTABLE SALT THEREOF
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
EA201000397A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
WO2013015530A3 (ko) 호두공급장치
WO2008093360A3 (en) A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride
EP2246343A4 (en) METHOD FOR PRODUCING A THIOPHENIC COMPOUND AND INTERMEDIATE PRODUCTS THEREFOR
IL212959A (en) Process for Preparing (6s) - (-) - 5,6,7,8- Tetrahydro-6- [Profile- (2-Thienyl) Ethyl] Amino-1-Solution (Rotigotine)
IL193402A0 (en) Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
EP1605756A4 (en) PREPARATION OF 5-METHYL-N-ARYL-2-PYRROLIDONE AND 5-METHYL-N-ALKYL-2-PYRROLIDONE BY REDUCING THE AMOUNT OF LOVERIC ACID ESTERS WITH ARYL AND ALKYLAMINES
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
ITMI20092020A1 (it) Procedimento per regolare un'oscillazione eccitata

Legal Events

Date Code Title Description
FA Abandonment or withdrawal